Variant
CTNNB1 Exon 3 Mutation
CI-VAR-00001019Explore in graph →CIViC 2892
Curated evidence
Evidence by cancer (15 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 15891929
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Adamantinomatous Craniopharyngioma3 | ||||||||
| CTNNB1 Exon 3 Mutation | (diagnostic) | Diagnostic | B | Supports Positive | 4 | submitted | EID12111Assessment of beta-catenin mutations in a large collections of pituitary adenomas (n=60) and craniopharynangiomas (n=41), identified CTNNB1 exon 3 mutations in 77% of craniopharynangiomas, all of the … (full text at CIViC) PMID 15891929 · Buslei et al., 2005 · Open in CIViC | civic |
| CTNNB1 Exon 3 Mutation | (diagnostic) | Diagnostic | B | Supports Positive | 4 | submitted | EID12112Whole-exome sequencing identified CTNNB1 mutations in 11 of 12 (92%) of adamantinomatous craniopharyngiomas examined. No other recurrent mutations or genomic aberrations were identified. Targeted se… (full text at CIViC) PMID 24413733 · Brastianos et al., 2014 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available